The South Proxa-Rescue AndroCoV Trial Against COVID-19
Status:
Completed
Trial end date:
2021-04-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy of proxalutamide or hospitalized
moderate-to-severe COVID-19 patients.
Phase:
Phase 3
Details
Lead Sponsor:
Corpometria Institute
Collaborators:
Hospital Arcanjo Sao Miguel, Gramado, Brazil Hospital da Brigada Militar de Porto Alegre, Porto Alegre, Brazil Hospital Unimed Chapeco, Chapeco, Brazil